Wave Life Sciences (NASDAQ:WVE)

Wave Life Sciences (NASDAQ:WVE) Pronounces Its Disappointment Over A Trial Flop

Monday morning was a dull one at Wave Life Sciences (NASDAQ:WVE). This was because the company’s shares declined by 50%. About the flop Analysts attribute this major drop to the recent discontinuation of the company’s suvodirsen. It was a product under development to help patients struggling with a condition known as Duchenne muscular dystrophy. DMD […]